Athenex submits Avechos phytonadione to FDA pre-IND
Filed with ASX · · 3 pages · English
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- Avecho receives ethics approval for Phase III CBD trial
- AVE signs development agreement with Perrigo
- September 2022 Quarterly Activities Report & Appendix 4C
- Increased CBD absorption in dogs vs commercial comparator
- June 2022 Quarterly Activities Report & Appendix 4C
Later from Avecho Biotechnology
- December 2022 Quarterly Activities Report & Appendix 4C
- Clinical CBD program expands with the Lambert Initiative
- Entitlement Offer to raise $11m for Phase 3 clinical trial
- Prospectus
- Investor Presentation
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology